<DOC>
	<DOCNO>NCT01966653</DOCNO>
	<brief_summary>Developed establishment structure process drug assessment , nitrofurantoin prescribe frequently give rise multi-resistant gram-negative pathogen . Doubts remain regard fosfomycin 's long-term clinical effectiveness . A randomized , control trial need explore clinical effectiveness well define side effect profile nitrofurantoin fosfomycin . This multi-center open trial randomize 600 non-pregnant woman three international site ( 200 Poland , Switzerland , Israel ) increase risk carriage resistant uropathogens suspicion uncomplicated low urinary tract infection receive either oral nitrofurantoin 100 mg three time daily 5 day single 3g dose oral fosfomycin . Patients follow clinical bacteriologic response day 14 28 post therapy completion . The study hypothesis hold nitrofurantoin superior fosfomycin clinical efficacy final follow-up .</brief_summary>
	<brief_title>Study Comparing Nitrofurantoin Fosfomycin Acute Urinary Tract Infection Women</brief_title>
	<detailed_description>Developed establishment structure process drug assessment , nitrofurantoin prescribe frequently give rise multi-resistant gram-negative pathogen . Doubts remain regard fosfomycin 's long-term clinical effectiveness . A randomized , control trial need explore clinical effectiveness well define side effect profile nitrofurantoin fosfomycin . From autumn 2013 summer 2016 , multi-center open trial randomize 600 non-pregnant woman three international site ( 200 Poland , Switzerland , Israel ) increase risk carriage resistant uropathogens suspicion uncomplicated low urinary tract infection receive either oral nitrofurantoin 100 mg three time daily 5 day single 3g dose oral fosfomycin . Patients follow clinical bacteriologic response day 14 28 post therapy completion . The study hypothesis hold nitrofurantoin superior fosfomycin clinical efficacy final follow-up .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Nitrofurantoin</mesh_term>
	<mesh_term>Fosfomycin</mesh_term>
	<criteria>Female gender Age â‰¥ 18 year Written inform consent At least one four key UTI symptom could attribute uncomplicated UTI , alternative explanation ( i.e . symptom suggestive STI vulvovaginitis ) : Dysuria Urgency ( include nocturia ) Frequency Suprapubic tenderness Urine dipstick test positive either nitrites leukocyte esterase Patient increase risk resistant pathogen , e.g. , FQresistant ESBLproducing Enterobacteriacae Male sex Pregnancy plan pregnancy Known carriage nitrofurantoin fosfomycinresistant uropathogens ( ) Concomitant antimicrobial therapy Use antibiotic past 7 day Known suspected hypersensitivity allergy fosfomycin nitrofurantoin History lung liver reaction peripheral neuropathy use nitrofurantoin nitrofuran past Preexisting polyneuropathy G6PD deficiency Symptoms consistent UTI precede 4 week Active upper UTI ( e.g . pyelonephritis , urosepsis : fever &gt; 38.0 , flank pain , chill ) Symptoms/signs suggestive vaginitis sexually transmit infection Indwelling catheter , nephrostomy , ureter stent foreign material Otherwise complicate UTI : A history anatomical functional abnormality urogenital tract : Congenital abnormality Polycystic kidney disease Obstruction stricture renal pelvis , ureter urethra Kidney stone Cystocele Cystic diverticulae Change anatomical proportion ( e.g . ureter implantation ) Chronic vesicourethral reflux Neurogenic bladder Severe chronic renal ( creatinine clearance &lt; 30 ml/min ) hepatic dysfunction Porphyria Immunosuppression : Untreated infection human immunodeficiency virus ( HIV ) Use highdose systemic corticosteroid immunosuppressive medication Chemotherapy Treatment radiation Critical illness require intensive care Planned surgery within next 6 week Inability take oral drug Participation another prospective clinical trial Previous enrolment propose study Inability understand follow study protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>nitrofurantoin</keyword>
	<keyword>fosfomycin</keyword>
	<keyword>urinary tract infection</keyword>
	<keyword>clinical efficacy</keyword>
	<keyword>bacteriologic response</keyword>
</DOC>